CLARITH Side Effects

6744956-0 | Nocardiosis, Rash
on May 21, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: nocardiosis, rash (What is rash?). Clarith dosage: . During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), KANAMYCIN (View Kanamycin Review and Kanamycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

6742463-2 | Clostridial Infection, Pouchitis
Patient was taking Clarith (View Usage). Patient had the following side effects: clostridial infection, pouchitis on May 18, 2010 from JAPAN Additional patient health information: Male patient , 32 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Clarith dosage: Intermittently 200mg-400mg. During the same period patient was treated with LEVOFLOXACIN (Intermittently 200mg) (View Levofloxacin Review and Levofloxacin Label ).

6741573-3 | Pneumonia
Adverse event was reported on May 14, 2010 by a Female patient taking Clarith (View Usage) (Dosage: ) was diagnosed with upper respiratory tract inflammation, upper respiratory tract infection and. Location: JAPAN , 37 years of age, After Clarith was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with KLARICID (View Klaricid Review and Klaricid Label ), LOXONIN (View Loxonin Review and Loxonin Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

6728296-1 | Nocardiosis, Rash
on May 10, 2010 Female patient from , 70 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: nocardiosis, rash (What is rash?). Clarith dosage: . During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), KANAMYCIN (View Kanamycin Review and Kanamycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.


6727922-0 | Clostridial Infection, Pouchitis
on May 11, 2010 Male patient from JAPAN , 32 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Clarith (View Usage). Patient had the following side effects: clostridial infection, pouchitis. Clarith dosage: Intermittently 200mg-400mg. During the same period patient was treated with LEVOFLOXACIN (Intermittently 200mg) (View Levofloxacin Review and Levofloxacin Label ).

6677325-2 | Hepatitis Acute, Liver Disorder
Patient was taking Clarith (View Usage). After Clarith was administered, patient had the following side effects: hepatitis acute, liver disorder on Apr 02, 2010 from JAPAN Additional patient health information: Male patient , weighting 124.8 lb, was diagnosed with infection (What is infection?), pyrexia, productive cough, gastric ulcer, asthma (What is asthma?) and. Clarith dosage: . During the same period patient was treated with IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), ANTOBRON (View Antobron Review and Antobron Label ), BLOSTAR M (View Blostar M Review and Blostar M Label ), FLUTIDE (View Flutide Review and Flutide Label ). Patient was hospitalized.

6663633-8 | Bronchiolitis, Stevens-johnson Syndrome
Adverse event was reported on Mar 23, 2010 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with mycoplasma infection, upper respiratory tract inflammation and. Location: JAPAN , child 5 years of age, Patient experienced the following unwanted or unexpected effects: bronchiolitis, stevens-johnson syndrome. During the same period patient was treated with LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ). Patient was hospitalized.

6647616-X | Interstitial Lung Disease
on Mar 23, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), schizophrenia, nasopharyngitis, constipation (What is constipation?), pyelonephritis and was treated with Clarith (View Usage). Patient had the following side effects: interstitial lung disease. Clarith dosage: . During the same period patient was treated with YOKUKAN SAN (View Yokukan-san Review and Yokukan-san Label ), MAOBUSHISAISHINTO (HERBAL MEDICINE) (View Maobushisaishinto (herbal Medicine) Review and Maobushisaishinto (herbal Medicine) Label ), MASHININGAN (HERBAL MEDICINE) (View Mashiningan (herbal Medicine) Review and Mashiningan (herbal Medicine) Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SPIRONOLACTONE (2t Daily) (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6641690-2 | Interstitial Lung Disease
on Mar 12, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), schizophrenia, nasopharyngitis, constipation (What is constipation?), pyelonephritis and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: interstitial lung disease. Clarith dosage: . During the same period patient was treated with YOKUKAN SAN (View Yokukan-san Review and Yokukan-san Label ), MAOBUSHISAISHINTO (HERBAL MEDICINE) (View Maobushisaishinto (herbal Medicine) Review and Maobushisaishinto (herbal Medicine) Label ), MASHININGAN (HERBAL MEDICINE) (View Mashiningan (herbal Medicine) Review and Mashiningan (herbal Medicine) Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SPIRONOLACTONE (2t Daily) (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6640902-9 | Bronchiolitis, Stevens-johnson Syndrome
Patient was taking Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: bronchiolitis, stevens-johnson syndrome on Mar 11, 2010 from JAPAN Additional patient health information: Male patient , child 5 years of age, was diagnosed with mycoplasma infection and. Clarith dosage: . During the same period patient was treated with LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ). Patient was hospitalized.

6635369-0 | Hepatitis Acute, Liver Disorder
Adverse event was reported on Mar 05, 2010 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), pyrexia, productive cough and. Location: JAPAN , weighting 124.8 lb, Patient had the following side effects: hepatitis acute, liver disorder. During the same period patient was treated with IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), ANTOBRON (View Antobron Review and Antobron Label ), BLOSTAR M (View Blostar M Review and Blostar M Label ), FLUTIDE (View Flutide Review and Flutide Label ). Patient was hospitalized.

6616712-5 | Uveitis
on Feb 24, 2010 Female patient from JAPAN , weighting 108.0 lb, was diagnosed with mycobacterial infection and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: uveitis. Clarith dosage: . During the same period patient was treated with RIFABUTIN (View Rifabutin Review and Rifabutin Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), PREDONINE (View Predonine Review and Predonine Label ).

6611946-8 | Hepatitis Acute, Liver Disorder
on Feb 23, 2010 Male patient from JAPAN , 44 years of age, was diagnosed with pyrexia, asthma (What is asthma?) and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute, liver disorder. Clarith dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDONINE (View Predonine Review and Predonine Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), ANTOBRON (View Antobron Review and Antobron Label ). Patient was hospitalized.

6583001-7 | Hepatitis Acute, Liver Disorder
Patient was taking Clarith (View Usage). Patient had the following side effects: hepatitis acute, liver disorder on Feb 10, 2010 from JAPAN Additional patient health information: Male patient , 44 years of age, was diagnosed with pyrexia, asthma (What is asthma?) and. Clarith dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDONINE (View Predonine Review and Predonine Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), ANTOBRON (View Antobron Review and Antobron Label ). Patient was hospitalized.

6554252-2 | Hepatic Failure, Jaundice
Adverse event was reported on Jan 18, 2010 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with chronic sinusitis, rhinitis allergic, constipation (What is constipation?) and. Location: JAPAN , weighting 158.7 lb, After Clarith was administered, patient had the following side effects: hepatic failure, jaundice (What is jaundice?). During the same period patient was treated with MUCODYNE (View Mucodyne Review and Mucodyne Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), PURSENNID (24 Mg Daily) (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

6523290-8 | Toxic Epidermal Necrolysis
on Dec 24, 2009 Female patient from JAPAN , 39 years of age, was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Clarith dosage: .

6522159-2 | Erythema Multiforme
on Dec 22, 2009 Female patient from JAPAN , 54 years of age, was diagnosed with helicobacter infection and was treated with Clarith (View Usage). Patient had the following side effects: erythema multiforme. Clarith dosage: . During the same period patient was treated with AMOLIN (View Amolin Review and Amolin Label ), TAKEPRON (View Takepron Review and Takepron Label ).

6505622-X | Pseudomembranous Colitis
Patient was taking Clarith (View Usage). After Clarith was administered, patient had the following side effects: pseudomembranous colitis on Dec 10, 2009 from JAPAN Additional patient health information: Female patient , 90 years of age, . Clarith dosage: . During the same period patient was treated with LOXONIN FGR (View Loxonin Fgr Review and Loxonin Fgr Label ).

6467945-2 | Erythema Multiforme
Adverse event was reported on Nov 25, 2009 by a Female patient taking Clarith (View Usage) (Dosage: ) was diagnosed with helicobacter infection and. Location: JAPAN , 54 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme. During the same period patient was treated with AMOLIN (View Amolin Review and Amolin Label ), TAKEPRON (View Takepron Review and Takepron Label ).

6455411-X | Toxic Epidermal Necrolysis
on Nov 16, 2009 Female patient from JAPAN , 39 years of age, was treated with Clarith (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Clarith dosage: .

6361989-7 | Pleural Effusion, Renal Failure Acute
on Sep 09, 2009 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with lung abscess, constipation (What is constipation?) and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: pleural effusion, renal failure acute. Clarith dosage: . During the same period patient was treated with LAXATIVES (View Laxatives Review and Laxatives Label ), PURSENNID (2 Tablets Daily) (View Pursennid Review and Pursennid Label ).

6347631-X | Leukocytoclastic Vasculitis
Patient was taking Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis on Sep 02, 2009 from JAPAN Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with allergy test positive, bronchitis (What is bronchitis?), leukocytoclastic vasculitis and. Clarith dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), L CARBOCYSTINE (View L-carbocystine Review and L-carbocystine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6333241-7 | Renal Failure Acute
Adverse event was reported on Aug 19, 2009 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with lung abscess, constipation (What is constipation?) and. Location: JAPAN , weighting 154.3 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with LAXATIVES (View Laxatives Review and Laxatives Label ), PURSENNID (View Pursennid Review and Pursennid Label ).

6317262-6 | Renal Failure Acute
on Aug 11, 2009 Male patient from JAPAN , 69 years of age, was diagnosed with lung abscess and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: renal failure acute. Clarith dosage: . Patient was hospitalized.

6313835-5 | Leukocytoclastic Vasculitis
on Aug 11, 2009 Male patient from JAPAN , weighting 145.5 lb, was diagnosed with allergy test positive, bronchitis (What is bronchitis?), leukocytoclastic vasculitis and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Clarith dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), L CARBOCYSTINE (View L-carbocystine Review and L-carbocystine Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6135867-2 | Pain, Pyrexia
Patient was taking Clarith (View Usage). Patient had the following side effects: pain (What is pain?), pyrexia on Mar 24, 2009 from JAPAN Additional patient health information: Female patient , 39 years of age, was diagnosed with pleurisy and. Clarith dosage: Not Reported. During the same period patient was treated with AMOXICILLIN (Not Reported) (View Amoxicillin Review and Amoxicillin Label ), METRONIDAZOLE (Not Reported) (View Metronidazole Review and Metronidazole Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (Not Reported) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

5095577-X | Depressed Level Of Consciousness, Hypoglycaemia
Adverse event was reported on Mar 27, 2006 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?), diabetes mellitus and. Location: JAPAN , 71 years of age, weighting 125.7 lb, After Clarith was administered, patient had the following side effects: depressed level of consciousness, hypoglycaemia. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

5080273-5 | Neutropenia
on Aug 04, 2006 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Clarith dosage: . During the same period patient was treated with DORIPENEM (View Doripenem Review and Doripenem Label ). Patient was hospitalized.

4624303-0 | Chest Pain, Status Asthmaticus
on Mar 23, 2005 Male patient from , child 9 years of age, weighting 97.00 lb, was diagnosed with bronchitis acute, asthma (What is asthma?) and was treated with Clarith (View Usage). Patient had the following side effects: chest pain (What is chest pain?), status asthmaticus. Clarith dosage: . During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), AZITHROMYCIN DIHYDRATE (View Azithromycin Dihydrate Review and Azithromycin Dihydrate Label ), DIMEMORFAN PHOSPHATE (View Dimemorfan Phosphate Review and Dimemorfan Phosphate Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), MEQUITAZINE (View Mequitazine Review and Mequitazine Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ). Patient was hospitalized.

4620932-9 | Anaemia, Bradycardia, Haemorrhagic Diathesis, Haemorrhagic Disorder, Ventricular Extrasystoles, Xanthopsia
Patient was taking Clarith (View Usage). After Clarith was administered, patient had the following side effects: anaemia, bradycardia, haemorrhagic diathesis, haemorrhagic disorder, ventricular extrasystoles, xanthopsia on Mar 18, 2005 from Additional patient health information: Female patient , 70 years of age, weighting 101.4 lb, was diagnosed with atypical mycobacterial infection, thrombosis prophylaxis, heart rate irregular, osteoporosis (What is osteoporosis?), insomnia and. Clarith dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

4613621-8 | Alveolitis Allergic, Dyspnoea Exertional, Hypoxia, Interstitial Lung Disease
Adverse event was reported on Mar 11, 2005 by a Female patient taking Clarith (View Usage) (Dosage: ) was diagnosed with upper respiratory tract inflammation and. Location: , 55 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: alveolitis allergic, dyspnoea exertional, hypoxia, interstitial lung disease. During the same period patient was treated with AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), CLOPERASTINE FENDIZOATE (View Cloperastine Fendizoate Review and Cloperastine Fendizoate Label ). Patient was hospitalized.

4591456-2 | Haemolytic Anaemia
on Feb 16, 2005 Female patient from , 70 years of age, was diagnosed with sinusitis (What is sinusitis?), hypertension and was treated with Clarith (View Usage). Patient had the following side effects: haemolytic anaemia. Clarith dosage: . During the same period patient was treated with FUDOSTEINE (View Fudosteine Review and Fudosteine Label ), APRICOT KERNEL WATER (View Apricot Kernel Water Review and Apricot Kernel Water Label ), CHERRY BARK EXTRACT (View Cherry Bark Extract Review and Cherry Bark Extract Label ), SIMPLE SYRUP (View Simple Syrup Review and Simple Syrup Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

4590683-8 | Henoch-schonlein Purpura, Pain In Extremity, Pharyngolaryngeal Pain, Pigmentation Disorder, Pyrexia
on Feb 15, 2005 Female patient from , 55 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: henoch-schonlein purpura, pain in extremity, pharyngolaryngeal pain, pigmentation disorder, pyrexia. Clarith dosage: . During the same period patient was treated with SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), ANTIBIOTICS RESISTANT LACTIC ACID BACTERIA (View Antibiotics-resistant Lactic Acid Bacteria Review and Antibiotics-resistant Lactic Acid Bacteria Label ), ANTIBIOTICS RESISTANT LACTIC ACID BACTERIA (View Antibiotics-resistant Lactic Acid Bacteria Review and Antibiotics-resistant Lactic Acid Bacteria Label ), TROXIPIDE (View Troxipide Review and Troxipide Label ).

4583160-1 | Schizophrenia
Patient was taking Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: schizophrenia on Feb 08, 2005 from Additional patient health information: Female patient , 76 years of age, weighting 110.2 lb, was diagnosed with upper respiratory tract inflammation, constipation (What is constipation?), insomnia, peripheral vascular disorder, osteoporosis (What is osteoporosis?) and. Clarith dosage: . During the same period patient was treated with PL (View Pl Review and Pl Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ).

4578915-3 | Interstitial Lung Disease, Pyrexia
Adverse event was reported on Feb 03, 2005 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), reflux oesophagitis, hyperuricaemia and. Location: , 79 years of age, weighting 93.92 lb, Patient had the following side effects: interstitial lung disease, pyrexia. During the same period patient was treated with PAZUFLOXACIN MESILATE (View Pazufloxacin Mesilate Review and Pazufloxacin Mesilate Label ), MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4578898-6 | Anaemia, Aortic Valve Replacement, C-reactive Protein Increased, Cardiac Failure Congestive, Constipation, Insomnia, Osteoporosis, Thrombocytopenia, Urinary Tract Infection
on Feb 02, 2005 Male patient from , 66 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, aortic valve replacement, cardiac failure congestive, anaemia, insomnia, behcet's syndrome (What is behcet's syndrome?) and was treated with Clarith (View Usage). After Clarith was administered, patient had the following side effects: anaemia, aortic valve replacement, c-reactive protein increased, cardiac failure congestive, constipation (What is constipation?), insomnia, osteoporosis (What is osteoporosis?), thrombocytopenia, urinary tract infection (What is urinary tract infection?). Clarith dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FERROUS CITRATE (View Ferrous Citrate Review and Ferrous Citrate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ). Patient was hospitalized.

4569606-3 | Hepatic Function Abnormal, Malaise, Rhabdomyolysis
on Jan 26, 2005 Male patient from , 75 years of age, was diagnosed with bronchitis chronic, gastritis, angina pectoris, hypothyroidism, asthma (What is asthma?), insomnia and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, malaise, rhabdomyolysis. Clarith dosage: . During the same period patient was treated with CIMETIDINE (View Cimetidine Review and Cimetidine Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRANLUKAST HYDRATE (View Pranlukast Hydrate Review and Pranlukast Hydrate Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), FUDOSTEINE (View Fudosteine Review and Fudosteine Label ), TELITHROMCYIN (View Telithromcyin Review and Telithromcyin Label ). Patient was hospitalized.

4563007-X | Abdominal Pain, Diarrhoea, Enterocolitis Haemorrhagic, Melaena
Patient was taking Clarith (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, enterocolitis haemorrhagic, melaena on Jan 19, 2005 from Additional patient health information: Female patient , 75 years of age, was diagnosed with helicobacter infection, gastric ulcer and. Clarith dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AZULENE SULFONATE SODIUM L GLUTAMINE (View Azulene Sulfonate Sodium-l-glutamine Review and Azulene Sulfonate Sodium-l-glutamine Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ). Patient was hospitalized.

4563006-8 | Haemolytic Anaemia
Adverse event was reported on Jan 17, 2005 by a Male patient taking Clarith (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: , 71 years of age, After Clarith was administered, patient had the following side effects: haemolytic anaemia. During the same period patient was treated with 1 (4 METHYLPHENYL)ETHYLNICOTINATE 1 NAPHTHYLACETIC ACID (View 1-(4-methylphenyl)ethylnicotinate 1-naphthylacetic Acid Review and 1-(4-methylphenyl)ethylnicotinate 1-naphthylacetic Acid Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), CAMOSTAT MESILATE (View Camostat Mesilate Review and Camostat Mesilate Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), BROMHEXINE HYDROCHLORIDE (View Bromhexine Hydrochloride Review and Bromhexine Hydrochloride Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), OXYPERTINE (View Oxypertine Review and Oxypertine Label ).

4563002-0 | Rash Erythematous
on Jan 20, 2005 Female patient from , child 10 years of age, was diagnosed with viral infection (What is viral infection?) and was treated with Clarith (View Usage). Patient experienced the following unwanted or unexpected effects: rash erythematous. Clarith dosage: . Patient was hospitalized.

4553942-0 | Anorexia, Dialysis, Hepatic Enzyme Increased, Hypersensitivity, Malaise, Nephritis Interstitial, Renal Failure Acute, Vomiting
on Jan 07, 2005 Female patient from , 72 years of age, weighting 88.41 lb, was diagnosed with upper respiratory tract infection, nasopharyngitis, upper respiratory tract inflammation, pyrexia and was treated with Clarith (View Usage). Patient had the following side effects: anorexia, dialysis (What is dialysis?), hepatic enzyme increased, hypersensitivity, malaise, nephritis interstitial, renal failure acute, vomiting. Clarith dosage: . During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), PL (View Pl Review and Pl Label ), CHERRY BARK EXTRACT CODEINE PHOSPHATE (View Cherry Bark Extract Codeine Phosphate Review and Cherry Bark Extract Codeine Phosphate Label ). Patient was hospitalized.

4546762-4 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder, Oedema
Patient was taking Clarith (View Usage). After Clarith was administered, patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, oedema on Jun 18, 2004 from Additional patient health information: Male patient , weighting 137.8 lb, was diagnosed with pneumonia (What is pneumonia?), gastritis, abdominal pain upper and. Clarith dosage: . During the same period patient was treated with THIATON (View Thiaton Review and Thiaton Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), TSUMURA SEIHAITOU (View Tsumura Seihaitou Review and Tsumura Seihaitou Label ), DEXTROMETHORPHAN HYDROBROMIDE (View Dextromethorphan Hydrobromide Review and Dextromethorphan Hydrobromide Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ). Patient was hospitalized.